How Retatrutide Revs Your Metabolism

Podcast: Foodnourish Deep Dives · Pavlos Giorkas

Opublikowano: 2026-10-23

In today's episode we're diving deep into retatrutide, Eli Lilly's experimental "Triple G" peptide that is reshaping metabolic medicine. We examine how this investigational triple-hormone receptor agonist targets GLP-1, GIP, and glucagon receptors simultaneously—not only curbing appetite like older treatments, but actively increasing resting energy expenditure to burn more calories. We review the latest clinical evidence, including pivotal Phase 3 TRIUMPH trial results where participants lost up to an average of 28.3% of their body weight over 80 weeks on the maximum 12 mg dose. We also break down the full safety profile, covering common gastrointestinal symptoms like nausea an...